ClinicalTrials.gg

GlaxoSmithKline: Schizophrenia trials

The registry lists 23 Schizophrenia studies with GlaxoSmithKline as lead sponsor. 0 are open to participants now and 1 have results posted.

Phase 1 15Phase 2 5Phase 3 2No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.